Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (381-390 of 390) with videos related to

Pageof 39
Sort By:
You have reached the last page of results.This site can display upto 390 results.
Blood Advances|July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGICYu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Annals of Hematology|July 6, 2026
Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective studyTaichiro Tokura, Satoshi Wakita, Keiko Fukunaga, et al.
International Journal of Hematology|August 22, 2019
Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemiaMasahiro Sakaguchi, Hiroki Yamaguchi, Marika Kuboyama, et al.
International Journal of Hematology|April 4, 2022
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemiaAtsushi Marumo, Satoshi Wakita, Kaoru Morita, et al.
Scientific Reports|February 7, 2026
Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemiaHiromi Hayashi, Takeo Yamagiwa, Junya Kanda, et al.
Transplantation and Cellular Therapy|May 18, 2026
Vaccine-Induced Anti-HBs Response Is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized TrialMasahiro Onozawa, Shigeru Kusumoto, Yachiyo Kuwatsuka, et al.
Cancer Science|January 7, 2023
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemiaSatoshi Wakita, Atsushi Marumo, Kaoru Morita, et al.
Ejhaem|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative StudyYasuyuki Arai, Ruta Brazauskas, Naya He, et al.
Blood Advances|August 27, 2021
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemiaSatoshi Wakita, Masahiro Sakaguchi, Iekuni Oh, et al.
Nature|July 8, 2026
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemiaYotaro Ochi, Markus Liew-Littorin, Yasuhito Nannya, et al.
Pageof 39

Showing results (381-390 of 390) with videos related to

Sort By:
Pageof 39
You have reached the last page of results.This site can display upto 390 results.
Blood Advances|July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGICYu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Annals of Hematology|July 6, 2026
Prognostic impact of KMT2A-PTD in acute myeloid leukemia in the NGS era: a multicenter retrospective studyTaichiro Tokura, Satoshi Wakita, Keiko Fukunaga, et al.
International Journal of Hematology|August 22, 2019
Significance of FLT3-tyrosine kinase domain mutation as a prognostic factor for acute myeloid leukemiaMasahiro Sakaguchi, Hiroki Yamaguchi, Marika Kuboyama, et al.
International Journal of Hematology|April 4, 2022
NPM1-mutation-based measurable residual disease assessment after completion of two courses of post-remission therapy is a valuable clinical predictor of the prognosis of acute myeloid leukemiaAtsushi Marumo, Satoshi Wakita, Kaoru Morita, et al.
Scientific Reports|February 7, 2026
Impact of venetoclax trough levels on safety and efficacy in the treatment of acute myeloid leukemiaHiromi Hayashi, Takeo Yamagiwa, Junya Kanda, et al.
Transplantation and Cellular Therapy|May 18, 2026
Vaccine-Induced Anti-HBs Response Is Associated with Protection Against Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Cell Transplantation: A Randomized TrialMasahiro Onozawa, Shigeru Kusumoto, Yachiyo Kuwatsuka, et al.
Cancer Science|January 7, 2023
Mutational analysis of DNMT3A improves the prognostic stratification of patients with acute myeloid leukemiaSatoshi Wakita, Atsushi Marumo, Kaoru Morita, et al.
Ejhaem|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative StudyYasuyuki Arai, Ruta Brazauskas, Naya He, et al.
Blood Advances|August 27, 2021
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemiaSatoshi Wakita, Masahiro Sakaguchi, Iekuni Oh, et al.
Nature|July 8, 2026
Chromatin landscape and epigenetic heterogeneity of acute myeloid leukaemiaYotaro Ochi, Markus Liew-Littorin, Yasuhito Nannya, et al.
Pageof 39